Overview of the Acquisition
RadNet Inc., a prominent outpatient imaging center operator, has acquired Kheiron Medical Technologies through its subsidiary, DeepHealth. This London-based firm specializes in using deep learning AI to assist radiologists in detecting breast cancer. The acquisition aims to enhance RadNet’s portfolio of AI-driven diagnostic solutions, particularly for breast cancer detection in Europe. The financial details of the deal remain undisclosed, but it follows RadNet’s pattern of investing in AI technologies to improve healthcare outcomes.
Key Highlights
- Kheiron’s product, Mia (Mammography Intelligent Assessment), is designed to improve the accuracy and efficiency of breast cancer detection.
- RadNet previously acquired DeepHealth in 2020 and has since invested heavily in AI firms, totaling around $140 million.
- DeepHealth’s offerings include Smart Mammo, a cloud-native software that aids in breast cancer diagnosis, charging women $40 for AI-assisted mammogram readings.
- RadNet’s Digital Health Division is projected to generate adjusted earnings of over $15 million this year, with revenues reaching up to $70 million.
Importance of the Move
This acquisition is significant as it positions RadNet to better support radiologists with advanced tools for breast cancer detection. The integration of Kheiron’s technology will likely enhance the quality of care provided to patients, ultimately leading to earlier detection of breast cancer. With rising breast cancer rates globally, such innovations are crucial in the fight against this disease. By expanding its AI capabilities, RadNet is not only improving its service offerings but also reinforcing its commitment to enhancing patient outcomes and healthcare efficiency.
